Johnson A, Tsitsikov E, Phan K, Zuccato J, Bauer A, Graffeo C
Front Oncol. 2024; 14:1506708.
PMID: 39726707
PMC: 11669715.
DOI: 10.3389/fonc.2024.1506708.
Schraps N, Port J, Menz A, Viehweger F, Buyucek S, Dum D
Cancer Med. 2024; 13(21):e70407.
PMID: 39533806
PMC: 11557986.
DOI: 10.1002/cam4.70407.
Zhou B, Li D, Chen X, Cai F, Cui J, Liu S
J Cancer Res Clin Oncol. 2024; 150(11):492.
PMID: 39527322
PMC: 11554903.
DOI: 10.1007/s00432-024-06016-6.
Salu P, Tuvin D, Reindl K
Biochim Biophys Acta Mol Cell Res. 2024; 1872(1):119854.
PMID: 39353469
PMC: 11608140.
DOI: 10.1016/j.bbamcr.2024.119854.
Wang L, Su J, Liu Z, Ding S, Li Y, Hou B
BioData Min. 2024; 17(1):20.
PMID: 38951833
PMC: 11218417.
DOI: 10.1186/s13040-024-00369-x.
Comprehensive analysis of exosome gene LYPD3 and prognosis/immune cell infiltration in lung cancer.
Xin T, Zheng C, Li G, Xu X, Zhang J, Jia C
Transl Cancer Res. 2024; 13(3):1394-1405.
PMID: 38617517
PMC: 11009804.
DOI: 10.21037/tcr-23-1557.
Prostate cancer research: tools, cell types, and molecular targets.
Liu A
Front Oncol. 2024; 14:1321694.
PMID: 38595814
PMC: 11002103.
DOI: 10.3389/fonc.2024.1321694.
Function and mechanism of exogenous AGR2 in colorectal cancer cells.
Zheng C, Mao Y, Ye J, Zhang M, Chen Y
Heliyon. 2024; 10(7):e28175.
PMID: 38560175
PMC: 10981063.
DOI: 10.1016/j.heliyon.2024.e28175.
Exploring Darunavir, Rilpivirine and Etravirine as Potential Therapies for Bladder Cancer: Efficacy and Synergistic Effects.
Pereira M, Vale N
Biomedicines. 2024; 12(3).
PMID: 38540260
PMC: 10968266.
DOI: 10.3390/biomedicines12030647.
AGR2: a secreted protein worthy of attention in diagnosis and treatment of breast cancer.
Zhang K, Li Y, Kong X, Lei C, Yang H, Wang N
Front Oncol. 2023; 13:1195885.
PMID: 37197416
PMC: 10183570.
DOI: 10.3389/fonc.2023.1195885.
Over-expression of Anterior Gradient 3 Is Associated With Tumor Progression and Poor Survival in Gastric Cancer.
Lee W, Park S, Park Y, Joo Y
In Vivo. 2023; 37(1):483-489.
PMID: 36593009
PMC: 9843753.
DOI: 10.21873/invivo.13103.
The anterior gradient homologue 2 (AGR2) co-localises with the glucose-regulated protein 78 (GRP78) in cancer stem cells, and is critical for the survival and drug resistance of recurrent glioblastoma: in situ and in vitro analyses.
Hussein D, Alsereihi R, Salwati A, Algehani R, Alhowity A, Al-Hejin A
Cancer Cell Int. 2022; 22(1):387.
PMID: 36482387
PMC: 9730595.
DOI: 10.1186/s12935-022-02814-5.
The genetics of monogenic intestinal epithelial disorders.
Babcock S, Flores-Marin D, Thiagarajah J
Hum Genet. 2022; 142(5):613-654.
PMID: 36422736
PMC: 10182130.
DOI: 10.1007/s00439-022-02501-5.
Identification of AGR2 Gene-Specific Expression Patterns Associated with Epithelial-Mesenchymal Transition.
Martisova A, Sommerova L, Krejci A, Selingerova I, Kolarova T, Zavadil Kokas F
Int J Mol Sci. 2022; 23(18).
PMID: 36142758
PMC: 9504245.
DOI: 10.3390/ijms231810845.
Anterior gradient proteins in gastrointestinal cancers: from cell biology to pathophysiology.
Boisteau E, Posseme C, Di Modugno F, Edeline J, Coulouarn C, Hrstka R
Oncogene. 2022; 41(42):4673-4685.
PMID: 36068336
DOI: 10.1038/s41388-022-02452-1.
Biomarker discovery for practice of precision medicine in hypopharyngeal cancer: a theranostic study on response prediction of the key therapeutic agents.
Kawata-Shimamura Y, Eguchi H, Kawabata-Iwakawa R, Nakahira M, Okazaki Y, Yoda T
BMC Cancer. 2022; 22(1):779.
PMID: 35841085
PMC: 9288037.
DOI: 10.1186/s12885-022-09853-1.